IMIC(SZ:000516) Xin Lang Cai Jing·2025-12-04 00:44Core Viewpoint - The company, International Medicine, plans to raise up to 1.008 billion yuan through a private placement of shares, with the funds allocated for smart healthcare projects, the second phase of the proton therapy center, and to supplement working capital [1][2]. Group 1: Fundraising and Project Allocation - The fundraising will support the transition of the company's business from traditional medical services to high-end radiation therapy, establishing a synergistic business model of "comprehensive diagnosis + precise radiation therapy" [1]. - A significant portion of the raised funds will be directed towards the smart healthcare project, utilizing idle spaces to enhance asset utilization and generate high-value healthcare services [1]. - The second phase of the proton therapy center aims to establish the first operational proton therapy project in Northwest China [2]. Group 2: Financial Performance and Debt Management - The company has experienced substantial losses over recent years, with cumulative losses of 2.621 billion yuan from 2021 to 2024 [3]. - In the first three quarters of 2025, the company reported a revenue of 2.995 billion yuan, a year-on-year decline of 16.94%, and a net loss of 294 million yuan, representing a 38.45% increase in losses compared to the previous year [3]. - The company has a high debt ratio of 68.80%, and the fundraising is expected to help reduce this ratio and optimize the capital structure [1].